Edition:
India

Catabasis Pharmaceuticals Reports Q2 Loss Per Share $0.20


Thursday, 9 Aug 2018 

Aug 9 (Reuters) - Catabasis Pharmaceuticals Inc ::CATABASIS PHARMACEUTICALS REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS AND REVIEWS BUSINESS PROGRESS.Q2 LOSS PER SHARE $0.20.Q2 EARNINGS PER SHARE VIEW $-0.23 -- THOMSON REUTERS I/B/E/S.AS OF JUNE 30, 2018, HAD CASH, CASH EQUIVALENTS OF $49.9 MILLION, COMPARED TO $17.0 MILLION AS OF MARCH 31, 2018.BASED ON CO'S CURRENT OPERATING PLAN, BELIEVES IT HAS SUFFICIENT CASH TO FUND OPERATIONS INTO Q2 2020. 

Company Quote

4.67
-0.14 -2.91%
18 Oct 2019